Saltar al contenido
Nutrición y metabolismoArtículo de investigación3 min read

Higher blood inflammation index linked to metabolic syndrome in 12,402 US adults

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Association between systemic immune-inflammation index and metabolic syndrome and its components: results from the National Health and Nutrition Examination Survey 2011-2016. · Journal of translational medicine · 2023 · Artículo original ↗

Idea principal

Among 12,402 US adults in NHANES 2011-2016, a higher systemic immune-inflammation index (SII) was associated with higher odds of metabolic syndrome (OR 1.33; 95% CI 1.14-1.55). It is a one-time survey snapshot, so it cannot show that inflammation causes metabolic syndrome, and the link was inverted-U shaped.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Metabolic syndrome (MetS), a cluster of waist, blood pressure, glucose and lipid problems, is thought to be tied to chronic inflammation. The authors tested whether SII, a simple blood-count inflammation marker, relates to MetS and to its individual components.

Población y método

Cross-sectional analysis of adults in the 2011-2016 National Health and Nutrition Examination Survey (NHANES) with complete SII and MetS data. MetS followed the National Cholesterol Education Program Adult Treatment Panel III criteria. SII was platelet count multiplied by neutrophil count divided by lymphocyte count, and participants were split into quartiles. Weighted linear regression, weighted multivariate logistic regression, subgroup analysis and restricted cubic splines were used.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of 12,402 participants, 3,489 had MetS. After adjustment, higher SII was linked to higher odds of MetS (OR 1.33; 95% CI 1.14-1.55).
  2. 2
    Waist circumference and blood pressure were positively linked to SII (waist OR 2.17; 95% CI 1.65-2.87; P < 0.001; blood pressure OR 1.65; 95% CI 1.20-2.27; P = 0.003). For HDL cholesterol the association was not significant (OR 1.29; 95% CI 0.99-1.67; P = 0.056).
  3. 3
    Gender, age and smoking status modified the SII and MetS link (P for interaction < 0.05).
  4. 4
    The relation was nonlinear: restricted cubic splines showed an inverted U-shaped association between SII and MetS.

Límites e incertidumbre

  1. 1
    Cross-sectional survey data, so it is unclear whether inflammation comes before MetS or results from it.
  2. 2
    SII is a single blood-count ratio from one sample, which can swing with infection, medication or smoking, and the abstract does not say how these were handled.
  3. 3
    The abstract describes the HDL result as a 'negative correlation' while reporting an odds ratio of 1.29 that was not significant, so the stated direction is unclear.
  4. 4
    The inverted-U shape means the abstract's simple message 'higher SII, more MetS' may not hold at the highest values.

Relevancia práctica

People with more systemic inflammation, as measured by this blood-count index, were somewhat more likely to have metabolic syndrome, especially a larger waist and higher blood pressure. This does not show that lowering SII or taking anti-inflammatory treatment would reduce metabolic syndrome. Testing and treatment decisions belong with a clinician.

Tus datos

SII comes from a lab blood count and cannot be tracked with a wearable. What you can record are waist measurements, home blood pressure readings with the same cuff, and weight trend, which map onto the components that were linked to SII.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Metabolic syndrome (MetS), a worldwide public health problem, affects human health and quality of life in a dramatic manner. A growing evidence base suggests that MetS is strongly associated with levels of systemic immune inflammation. The present study aimed to investigate the possible relationship between the systemic immune-inflammation index (SII), a novel inflammatory marker, and MetS to provide data support for effective MetS prevention by reducing the systemic inflammatory response.

Methods

We included adult participants with complete SII and MetS information from the 2011-2016 National Health and Nutrition Examination Survey (NHANES). MetS was defined as using the criteria developed by the Adult Treatment Program III of the National Cholesterol Education Program. The formula for SII was as follows: SII = platelet counts × neutrophil counts/ lymphocyte counts. Weighted linear regression was used to assess differences in variables across SII quartile groups after the SII score was divided into 4 quartiles. The independent interaction between SII and MetS was investigated using weighted multivariate logistic regression analysis and subgroup analysis, and the relationship between SII levels and 5 particular MetS items was further explored in depth.

Results

A total of 12,402 participants, 3,489 of whom were diagnosed with MetS, were included in this study. After correcting for covariates, the results of a logistic regression of multistage weighted complex sampling data revealed that participants with higher SII scores had a higher chance of developing MetS (odds ratio (OR) = 1.33, 95% confidence interval (CI): 1.14-1.55) and that SII levels could be used as an independent risk factor to predict that likelihood of MetS onset. In the Q1-Q4 SII quartile group, the risk of developing MetS was 1.33 times higher in the Q4 group, which had the highest level of systemic immune inflammation than in the Q1 group. After adjusting for all confounding factors, SII scores were found to have a negative correlation with high-density lipoprotein cholesterol (OR = 1.29; 95% CI, 0.99-1.67, P = 0.056) and a significant positive correlation with waist circumference (OR = 2.17; 95% CI, 1.65-2.87, P < 0.001) and blood pressure (BP) (OR = 1.65; 95% CI, 1.20-2.27, P = 0.003). Gender, age, and smoking status were shown to alter the positive association between SII and MetS in subgroup analyses and interaction tests (p for interaction < 0.05). Additionally, we demonstrated a nonlinear correlation between SII and MetS. The findings of the restricted cubic spline indicated that there was an inverted U-shaped association between SII and MetS.

Conclusions

Our findings imply that increased SII levels are related to MetS, and SII may be a simple and cost-effective method to identify individuals with MetS. Therefore, protective measures such as early investigation and anti-inflammatory interventions are necessary to reduce the overall incidence of MetS.

Fuentes y atribución

Association between systemic immune-inflammation index and metabolic syndrome and its components: results from the National Health and Nutrition Examination Survey 2011-2016.

Zhao Y, Shao W, Zhu Q, Zhang R, Sun T, Wang B, Hu X.

Journal of translational medicine · 2023-10-04

DOI: 10.1186/s12967-023-04491-y ↗PubMed · 37794370 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis de ensayos

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Nutrición y metabolismo →